🇺🇸 FDA
Pipeline program

[14C]-tebapivat

AG946-C-004

Phase 1 small_molecule completed

Quick answer

[14C]-tebapivat for Healthy Participants is a Phase 1 program (small_molecule) at AGIOS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
AGIOS PHARMACEUTICALS, INC.
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials